Alice Gage
YOU?
Author Swipe
View article: Kidney Transplant Outcomes With Non-Depleting Antibody Induction Therapy in Human Leucocyte Antigen Sensitised Recipients
Kidney Transplant Outcomes With Non-Depleting Antibody Induction Therapy in Human Leucocyte Antigen Sensitised Recipients Open
Lymphocyte depleting induction is recommended for kidney transplant recipients (KTRs) at high immunological risk, which traditionally includes those with detectable anti-human leucocyte antigen antibodies. Data to support this approach in …
View article: Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis
Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis Open
Introduction: Focal segmental glomerulosclerosis (FSGS) is associated with podocyte damage resulting in cytoskeletal alterations leading to foot process effacement. Vincristine is a chemoprotective drug which alters cytoskeletal microtubul…
View article: WCN25-2341 OUTCOMES OF KIDNEY TRANSPLANTATION FROM DECEASED DIABETIC DONORS: SINGLE CENTER STUDY
WCN25-2341 OUTCOMES OF KIDNEY TRANSPLANTATION FROM DECEASED DIABETIC DONORS: SINGLE CENTER STUDY Open
View article: Outcomes following kidney transplantation in patients with sickle cell disease: The impact of automated exchange blood transfusion
Outcomes following kidney transplantation in patients with sickle cell disease: The impact of automated exchange blood transfusion Open
There are over 12,000 people with sickle cell disease (SCD) in the UK, and 4-12% of patients who develop Sickle Cell Nephropathy (SCN) progress to End Stage Renal Disease (ESRD). Renal transplantation offers the best outcomes for these pat…